Stocks and Investing
by (remove) : Cory Kasimov
RSSJSONXMLCSV
Stocks and Investing
by (remove) : Cory Kasimov
RSSJSONXMLCSV
Wed, August 7, 2024
Tue, August 6, 2024
Tue, May 14, 2024
Tue, December 21, 2021
Wed, February 17, 2021
Wed, July 29, 2020
Thu, June 18, 2020
Wed, March 18, 2020
Fri, February 14, 2020
Mon, November 4, 2019
Wed, October 23, 2019
Thu, August 29, 2019
Wed, October 24, 2018
Fri, July 27, 2018
Thu, May 31, 2018
Wed, January 24, 2018
Fri, October 21, 2016
Fri, August 5, 2016
Thu, June 18, 2015
Mon, June 15, 2015
Wed, May 27, 2015
Thu, February 26, 2015
Tue, February 10, 2015
Thu, December 11, 2014
Wed, June 18, 2014

Cory Kasimov Maintained (BBIO) at Buy with Decreased Target to $45 on, Aug 7th, 2024


Published on 2024-10-28 13:18:45 - WOPRAI, Cory Kasimov
  Print publication without navigation


Cory Kasimov of Evercore ISI Group, Maintained "BridgeBio Pharma, Inc." (BBIO) at Buy with Decreased Target from $50 to $45 on, Aug 7th, 2024.

Cory has made no other calls on BBIO in the last 4 months.



There are 4 other peers that have a rating on BBIO. Out of the 4 peers that are also analyzing BBIO, 0 agree with Cory's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Cory


  • Raghuram Selvaraju of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $43 on, Monday, August 5th, 2024
  • Josh Schimmer of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $70 on, Monday, July 1st, 2024
  • Geoff Meacham of "B of A Securities" Maintained at Strong Buy with Decreased Target to $42 on, Tuesday, June 25th, 2024
  • Eliana Merle of "UBS" Maintained at Strong Buy with Decreased Target to $47 on, Tuesday, May 28th, 2024
Contributing Sources